Skip to main content

Sacrosidase Pregnancy and Breastfeeding Warnings

Brand names: Sucraid

Medically reviewed by Drugs.com. Last updated on Sep 26, 2024.

Sacrosidase Pregnancy Warnings

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: Not assigned

Risk summary: No data are available on the use of this drug in pregnant women to inform a drug-related risk.

Animal studies have not been reported. There are no controlled data in human pregnancy.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

See references

Sacrosidase Breastfeeding Warnings

The manufacturer makes no recommendation regarding use during lactation.

Excreted into human milk: Unknown
Excreted into animal milk: Unknown

Comment: The effects in the nursing infant are unknown.

See references

Does Sacrosidase interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

See also

References for pregnancy information

  1. (2001) "Product Information. Sucraid (sacrosidase)." Orphan Medical
  2. (2024) "Product Information. Sucraid (sacrosidase)." QOL Medical LLC, SUPPL-31

References for breastfeeding information

  1. (2001) "Product Information. Sucraid (sacrosidase)." Orphan Medical

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer